Available Trials

Drop to.. -Select- Anal Cancer Breast Cancer Endometrial Cancer Gastric Head and Neck Leukemia Lung Cancer Lymphoma Multiple Myeloma Myelofibrosis Neutropenia Ovarian Cancer Pancreatic Cancer Prostate Cancer Renal Cancer Skin Cancer Solid Tumors Rare Malignancies Urothelial Cancer

Anal Cancer

• STAR 18134

  Locally advanced or metastatic Squamous Carcinoma of the Anal Canal

  Available at 4 locations

Breast Cancer

• USOR 17188

  High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

  Available at 5 locations

• STAR14059

  HER2 Amplified Metastatic Breast Cancer

  Available at 8 locations

• USOR 18232

  Tripple Negative Breast Cancer (TNBC), Ovarian Cancer, Gynecologic Malignancies

  Available at 1 location

• USOR18109

  All Pathologies/Patients

  Available at 7 locations

• USOR17079

  Clinical Data to Evaluate New Gene Expression Profiles (A Registry), All Comers Applicable

  Available at 7 locations

• NSABP B59

  Triple-Negative Breast Cancer

  Available at 2 locations

• USOR 17009

  HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer (ER+/PR+/HER2- )

  Available at 7 locations

• USOR 16128

  ER+/HER2- Breast Cancer

  Available at 7 locations

Endometrial Cancer

• USOR 17197

  Advanced Endometrial Cancer

  Available at 7 locations

Gastric

• STAR 18016

  Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

  Available at 8 locations

• USOR 18233

  Gastrointestinal Malignancies (GEC, CRC)

  Available at 1 location

Head and Neck

• USOR 18020

  Squamous Cell Carcinoma of the Head and Neck, Non-Small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Urothelial Cell Cancer

  Available at 1 location

• USOR 17132

  Advanced Squamous Cell Carcinoma of the Head and Neck

  Available at 6 locations

Leukemia

• AZA-MDS-006

  Myelodysplastic syndromes (MDS) or Acute Myeloid Leukemia (AML) on Bone Marrow

  Available at 6 locations

Lung Cancer

• STAR 18164

  Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors with RET fusion

  Available at 8 locations

• STAR 18129

  Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

  Available at 8 locations

• STAR 18076

  Stage IIIB (locally advanced or recurrent and not a candidate for curative therapy) or stage IV Advanced Non–Small-Cell Lung Cancer

  Available at 8 locations

• STAR 17143

  Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation

  Available at 8 locations

• USOR18109

  All Pathologies/Patients

  Available at 7 locations

• USOR 18020

  Squamous Cell Carcinoma of the Head and Neck, Non-Small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Urothelial Cell Cancer

  Available at 1 location

• USOR 17192

  non-Small Cell Lung Cancer

  Available at 1 location

• USOR 17038

  Advanced Solid Tumor Malignancies, Any Loss of function mutation in CBL, Genetic Alteration in AXL

  Available at 1 location

• USOR 17199

  Metastatic Non-Small Cell Lung Cancer Expressing High Levels of PD-L1

  Available at 7 locations

• USOR 17167

  Non-Small Cell Lung Cancer, stages II-IIIA and IIIB (T>5cm N2) completely resected (R0)

  Available at 4 locations

• USOR 16156

  Non-Small Cell Lung Cancer High Tumor Mutation Burden

  Available at 7 locations

Lymphoma

• USOR18109

  All Pathologies/Patients

  Available at 7 locations

• STAR 16248

  Follicular Lymphoma with EZH2 mutation

  Available at 8 locations

• STAR 11282

  Hodkin Lymphoma (HL) in Adults Age 60 and Above

  Available at 8 locations

• USOR 16065

  Follicular Lymphoma, Non-Hodgkin’s Lymphoma, Mantle Cell Lymphoma

  Available at 7 locations

Multiple Myeloma

• USOR 18020

  Squamous Cell Carcinoma of the Head and Neck, Non-Small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Urothelial Cell Cancer

  Available at 1 location

• USOR 16035

  Multiple Myeloma

  Available at 7 locations

Myelofibrosis

• STAR 17085

  Myelofibrosis, post-poycythemia vera myelofibrosis, post essential thrombocytopenia myelo fibrosis

  Available at 8 locations

Neutropenia

• USOR18109

  All Pathologies/Patients

  Available at 7 locations

Ovarian Cancer

• USOR 18232

  Tripple Negative Breast Cancer (TNBC), Ovarian Cancer, Gynecologic Malignancies

  Available at 1 location

Pancreatic Cancer

• GHPANC1-001

  Adenocarcinoma of Pancreas

  Available at 1 location

Prostate Cancer

• USOR 17146

  Metastatic Castration Resistant Prostate Cancer

  https://clinicaltrials.gov/ct2/show/NCT03480646?term=03480646&rank=1

  Available at 1 location

• STAR 16238

  Metastatic Castration-resistant Prostate Cancer (mCRPC) with BRCA1/2 mutation or ATM

  Available at 8 locations

• USOR 18128

  Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  Available at 8 locations

• USOR18109

  All Pathologies/Patients

  Available at 7 locations

• STAR 16237

  Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  Available at 8 locations

• USOR 17149

  Castration-resistant Metastatic Prostate Cancer

  Available at 4 locations

Renal Cancer

• USOR 18020

  Squamous Cell Carcinoma of the Head and Neck, Non-Small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Urothelial Cell Cancer

  Available at 1 location

• USOR 16251

  Renal Cell Carcinoma Clear Cell Component

  Available at 6 locations

• USOR 16145

  Clear Renal Cell Carcinoma

  Available at 7 locations

Skin Cancer

• USOR 17038

  Advanced Solid Tumor Malignancies, Any Loss of function mutation in CBL, Genetic Alteration in AXL

  Available at 1 location

Solid Tumors

• STAR 18164

  Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors with RET fusion

  Available at 8 locations

• STAR 16248

  Follicular Lymphoma with EZH2 mutation

  Available at 8 locations

• USOR 16041

  Lynch Syndrome, Medullary, Neuroendocrine- Poorly Differentiated, Testicular, Vulvar

  Available at 5 locations

• USOR 17063

  Advanced Solid Tumors Except Non-Small Cell Lung Cancer

  Available at 1 location

• USOR 17038

  Advanced Solid Tumor Malignancies, Any Loss of function mutation in CBL, Genetic Alteration in AXL

  Available at 1 location

Rare Malignancies

• USOR 16041

  Lynch Syndrome, Medullary, Neuroendocrine- Poorly Differentiated, Testicular, Vulvar

  Available at 5 locations

Urothelial Cancer

• USOR 18283

  urothelial or non-urothelial carcinoma of the urinary tract

  Available at 7 locations

• USOR 18020

  Squamous Cell Carcinoma of the Head and Neck, Non-Small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Urothelial Cell Cancer

  Available at 1 location

• USOR 17165

  Metastatic or Surgically Unresectable Urothelial Cancer, Transitional Cell Carcinoma FGFR2, FGFR3 mutations.

  Available at 1 location

• STAR 15228

  Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  Available at 8 locations

• USOR 17005

  Advanced or Metastatic Urothelial Cancer

  Available at 6 locations